News in Ophthalmology (articoli presenti: 642)

Scorri le pagine : 1 di 22

28/05/2018 - ZEISS UNVEILS ULTRA-WIDEFIELD FUNDUS IMAGING TECHNOLOGY IN U.S.

ZEISS CLARUS 500 aids ocular disease detection with exceptional True Color imaging clarity from the macula to peripheryDUBLIN, CA / LAS VEGAS, NV, September 14, 2017 ZEISS CLARUS™ 500 Ultra-widefield system leverages legendary ZEISS precision optics to provide high resolution ret...

23/05/2018 - IMMUNE MECHANISMS IN ALLERGIC EYE DISEAS

Feb 26, 2018Reviewed by Dr Andrea Leonardi Ocular allergy affects millions of people worldwide. It is generally intermittent but sufferers’ quality of life is affected by the resulting ocular discomfort and inflammation: in severe cases they may experience vision disturban...

23/05/2018 - STEROID AND NSAID COMBINATION PREVENTS MACULAR OEDEMA AFTER CATARACTS

By Laird Harrison Nov 2, 2017 OTE Articles, OTE Articles, Modern Medicine Cases, Modern Medicine Feature Articles, Modern Medicine News, Cataract OTE, IOLs, OTE Articles, Cataract A combination of a topical corticosteroid and a nonsteroidal anti-inflammatory drug (NSAID) is more ...

23/05/2018 - PREVALENCE AND CAUSES OF VISION LOSS TABULATED

By Laird Harrison May 16, 2018 Ophthalmic News, AMD, Cataract, Glaucoma, Refractive Cataract remains the most common causes of blindness worldwide, followed by uncorrected refractive error, glaucoma, age-related macular degeneration (AMD), cornea-related diseases, trachoma and di...

05/04/2018 - THE USE OF OPTICAL COHERENCE TOMOGRAPHY IN NEURO-OPHTHALMOLOGY

ByNoel C.Y. Chan; Carmen K.M. Chan Current Opinion in Ophthalmology. 28(6):552–557, NOV 2017 DOI: 10.1097/ICU.0000000000000418 ,   PMID: 28806189 ...

20/03/2018 - MÜLLER CELLS AND DIABETIC RETINOPATHY.

Vision Res. 2017 Oct;139:93-100. doi: 10.1016/j.visres.2017.03.013. Epub 2017 Sep 5. Coughlin BA1, Feenstra DJ1, Mohr S2 Abstract Müller cells are one of the primary glial cell types found in the retina and play a significant role in maintaining retinal function and health. ...

15/03/2018 - THE USE OF OPTICAL COHERENCE TOMOGRAPHY IN NEURO-OPHTHALMOLOGY

The use of optical coherence tomography in neuro-ophthalmologyNoel C.Y. Chan; Carmen K.M. Chan AbstractPurpose of reviewIn the last decade, with the advances of optical coherence tomography (OCT) technology, different imaging protocols and analysis algorithms have been introduced...

08/02/2018 - THE USE OF OPTICAL COHERENCE TOMOGRAPHY IN NEURO-OPHTHALMOLOGY.

The use of optical coherence tomography in neuro-ophthalmology.Chan NCY1, Chan CKM.Author information1a Hong Kong Eye Hospital bDepartment of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong, Hong Kong.AbstractPURPOSE OF REVIEW: In the last decade, with the ...

21/12/2017 - PACHYCHOROID PIGMENT EPITHELIOPATHY.

Retina. 2013 Sep;33(8):1659-72. doi: 10.1097/IAE.0b013e3182953df4. Pachychoroid pigment epitheliopathy. Warrow DJ1, Hoang QV, Freund KB. PURPOSE:  To report nine cases of pachychoroid pigment epitheliopathy. METHODS:  An observational case series of nine patients who u...

19/12/2017 - THE EXPANDED SPECTRUM OF PERIFOVEAL EXUDATIVE VASCULAR ANOMALOUS COMPLEX

by Riccardo Sacconi et alAffiliationsPurposeTo expand our understanding of the uncommon entity, referred to as perifoveal exudative vascular anomalous complex (PEVAC) by describing multimodal imaging findings, including optical coherence tomography angiography (OCT-A).DesignRetro...

18/12/2017 - PARACENTRAL ACUTE MIDDLE MACULOPATHY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURE OF DEEP CAPILLARY ISCHEMIA

by Ehsan Rahimy; David Sarraf  Purpose of Review To describe the novel spectral-domain optical coherence tomography (SD-OCT) finding of paracentral acute middle maculopathy (PAMM) that can be associated with acute macular neuroretinopathy (AMN) or retinal vasculopathy...

27/11/2017 - EVALUATION OF SEGMENTATION OF THE SUPERFICIAL AND DEEP VASCULAR LAYERS OF THE RETINA BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY INSTRUMENTS IN NORMAL EYES

JAMA Ophthalmol. 2017 Mar 1;135(3):259-262. doi: 10.1001/jamaophthalmol.2016.5327. Spaide RF1, Curcio CA2. Author information Abstract Importance:  Correct attribution of vascular features in optical coherence tomography (OCT) angiography depends on accurate segmentation of ...

24/10/2017 - NOVEL BROLUCIZUMAB FOSTERS AS REAL-WORLD ALTERNATIVE FOR NAMD

October 23, 2017 By Cheryl Guttman Krader    Reviewed by Pravin U. Dugel, MD Topline results from phase III studies investigating intravitreal brolucizumab (Novartis) for treatment of neovascular age-related macular degeneration (nAMD) support the potential of this...

20/10/2017 - ANGIOPLEX MAY HELP DETECT ASYMPTOMATIC CHOROIDAL NEOVASCULARIZATION IN DRY AM

By Philip J. Rosenfeld, MD, PhD I have maintained a research relationship with ZEISS for well over 10 years, and thus I have been involved in the development of the spectral-domain CIRRUS HD-OCT (ZEISS) system, as well as the new angiography platform known as AngioPlex OCT-angio...

20/10/2017 - WHAT DO YOU FEEL ARE THE CLINICAL BENEFITS OF USING THE CIRRUS OCT-HD WITH ANGIOPLEX OCT-ANGIOGRAPHY?

My team and I have been using the CIRRUS prototype on an almost daily basis for the past few months to study eyes that we suspect of having macular or retinal pathology. High-definition OCT angiography (OCT-A) enables us to conduct an exploratory examination of what we think may...

20/10/2017 - WHAT ARE THE PRIMARY ADVANTAGES OF OCT-A?

OCT-A stands for optical coherence tomography-angiography, which is a promising technology still under investigation. Currently, fluorescein angiography (FA) is the standard of care for evaluating numerous retinal diseases, but it requires the intravenous injection of a dye with...

26/09/2017 - OPTICAL COHERENCE TOMOGRAPHY MARKET WORTH $1.8 BILLION BY 2024

Optical Coherence Tomography Market Worth $1.8 Billion By 2024September 2016 | Report Format: Electronic (PDF) The global optical coherence tomography (OCT) market is expected to reach USD 1.8 billion by 2024, according to a new report by Grand View Research, Inc. Incr...

26/09/2017 - OPTICAL COHERENCE TOMOGRAPHER MARKET EXPECTED TO GROW 5.4 PERCENT BY 2021

Optical Coherence Tomographer Market Expected to Grow 5.4 Percent by 2021 March 15, 2016: By Market Scope Market Scope estimates that the optical coherence tomographer (OCT) market will generate $650 million in total end-user revenues in 2016. We look for the market to g...

03/09/2017 - A REVIEW OF MICROPULSE LASER PHOTOCOAGULATION

A Review of Micropulse Laser PhotocoagulationTransplanting the entire cornea used to be the only option available to patients with debilitating corneal diseases. Now, ever-improving lamellar procedures can help most of these patients. --> By Carolyn Majcher, O.D., and And...

28/08/2017 - SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY REVEALS CHORIOCAPILLARIS ALTERATIONS IN EYES WITH NASCENT GEOGRAPHIC ATROPHY AND DRUSEN-ASSOCIATED GEOGRAPHIC ATROPHY

by: Moult, Eric M. BSc; Waheed, Nadia K. MD, MPH; Novais, Eduardo A. MD; Choi, WooJhon PhD; Lee, ByungKun MEng; Ploner, Stefan B. BSc; Cole, Emily D. BSc; Louzada, Ricardo N. MD; Lu, Chen D. MSc; Rosenfeld, Philip J. MD, PhD; Duker, Jay S. MD; Fujimoto, James G. PhDPurpose: ...

26/07/2017 - NEW PRODUCT APPLICATIONS: OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AT ITS FINEST

Optovue’s AngioVueHD provides the widest high-resolution images.By KAREN APPOLD, CONTRIBUTING WRITERJuly 1, 2017 Optical coherence tomography (OCT) angiography, or OCTA imaging, provides wider fields of view at high resolution. “However, while a 3 mm x 3 mm image on OCTA generall...

05/07/2017 - NUOVE TERAPIE: LUTEINA

Nuove terapie: luteinaEvidenze clinico-scientifiche suggeriscono che l'apporto di luteina può portare vantaggi in pazienti con degenerazione maculare senile secca o atrofica.La causa della degenerazione maculare legata all'età (AMD) è sicuramente multifattoriale. Infat...

05/07/2017 - VEGF TRAP-EYE (AFLIBERCEPT OPHTHALMIC SOLUTION) - OPHTHALMOLOGIC DRUGS ADVISORY COMMITTEE

VEGF TRAP-EYE (aflibercept ophthalmic solution) - OPHTHALMOLOGIC DRUGS ADVISORY COMMITTEEJune 17, 2011 - Executive Summary Age-related macular degeneration (AMD) is the most common cause of legal blindness in the elderly population of the developed world. A major paradigm sh...

05/07/2017 - EYLEA - IL NUOVO ANTI VEGF PER LA DEGENERAZIONE MACULARE UMIDA

EYLEA - Il nuovo anti VEGF per la degenerazione maculare umida L'introduzione dei nuovi farmaci che contrastano il fattore di crescita neovascolare (VEGF) nella degenerazione maculare senile ha cambiato radicalmente l'efficacia della cura permettendo di avere il 90% di s...

15/06/2017 - ZEISS APPOINTS JIM MAZZO AS GLOBAL PRESIDENT OF OPHTHALMOLOGY

Carl Zeiss Meditec appointed James V. Mazzo as global president of ophthalmology, according to a company press release. In this role, Mazzo will be responsible for leading the new strategic business unit of ophthalmology and the company’s U.S. sales and service center.  Jame...

14/06/2017 - WIDE FIELD AND HIGHLY SENSITIVE ANGIOGRAPHY WIDE FIELD AND HIGHLY SENSITIVE ANGIOGRAPHY WIDE FIELD AND HIGHLY SENSITIVE ANGIOGRAPHY WIDE FIELD AND HIGHLY SENSITIVE ANGIOGRAPHY WIDE FIELD AND HIGHLY SENSITIVE ANGIOGRAPHY WIDE FIELD AND HIGHLY SENSITIVE ANG

JINGJIANG XU, SHAOZHEN SONG, WEI WEI, AND RUIKANG K. WANG*University of Washington, Department of Bioengineering, Seattle, Washington 98195, USA*wangrk@uw.edu Abstract: Wide-field vascular visualization in bulk tissue that is of uneven surface is challenging due to the relativel...

24/05/2017 - JIM MAZZO GLOBAL PRESIDENT OPHTHALMIC DEVICES CARL ZEISS MEDITEC

Jim MazzoGlobal President Ophthalmic DevicesCarl Zeiss MeditecBiography James V. Mazzo is Global President for Carl Zeiss Meditec’s Strategic Business Unit Ophthalmic Devices, which includes Ophthalmic Diagnostics, Surgical Ophthalmology and Refractive Lasers. He also heads the ...

24/05/2017 - JAMES MAZZO MAKES HIS MARK WITH MOVE TO CARL ZEISS

James Mazzo makes his mark with move to Carl ZeissIt’s all about customer service, says new Global President Ophthalmic Devices at Zeiss Howard Larkin Posted: Tuesday, November 1, 2016 Since beginning his career in ophthalmic products at Allergan 36 years ago, James Mazzo always ...

26/04/2017 - RELATIONSHIP BETWEEN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VESSEL DENSITY AND SEVERITY OF VISUAL FIELD LOSS IN GLAUCOMA

by: Adeleh Yarmohammadiet al In conclusion, OCT-A vessel density measurements are significantly associated with the severity of visual field damage. These associations are generally stronger than standard structural measures such as RNFL and rim area.Moreover, OCT-A vessel densit...
Scorri le pagine : 1 di 22
Ricerca Oculisti

Le Interviste per Oftalmologia domani

INTERVISTA CONGRESSO SOI 2016 - DOTT. AMEDEO LUCENTE